Vladimir Badmaev | Pharma | Industry Impact Award

Posted on by ScienceFather

Dr. Vladimir Badmaev  –  Pharma  –  Industry Impact Award

Alignment with Award Category

Dr. Badmaev’s research and innovations align seamlessly with the Industry Impact Award criteria. His pioneering work in natural pharma and smart drug development, along with his numerous patents and product contributions, make him a highly deserving candidate.

American Medical Holdings Inc. | United States

Profile

Orcid

Scopus

🎓Early Academic Pursuits 

Education and Training

Vladimir Badmaev, MD, PhD, embarked on his academic journey at the Medical Academy of Bialystok (AMB) in Poland, where he graduated in 1975. His early academic years laid a strong foundation in medical sciences, leading him to specialize in clinical and anatomical pathology. He pursued his specialization at Kings County Hospital, New York, and Downstate Medical Center, New York, between 1982 and 1985. During this period, he honed his expertise in understanding disease mechanisms and diagnostic techniques. Additionally, in 1978, he obtained his PhD in immunopharmacology from AMB, reflecting his deep interest in the interaction between the immune system and pharmacological agents. His academic credentials positioned him as a leader in integrative medicine, combining traditional knowledge with scientific advancements.

💼Professional Endeavors 

Academic Positions

Dr. Badmaev’s professional career has been defined by his dedication to bridging traditional botanical medicine with modern pharmacological science. In 1984, he established the Badmaev Natural Drug Foundation, an organization committed to exploring the therapeutic potential of natural compounds. Later, in 2009, he founded American Medical Holdings Inc. in Staten Island, New York, to advance the development of nutraceuticals and natural pharmaceutical products. Through these initiatives, he has played a crucial role in integrating the principles of traditional medicine with contemporary scientific research. His company, www.badmaevtradition.com, stands as a testament to his lifelong commitment to safe and effective alternative medicine solutions.

📚Contributions and Research Focus on Pharma

Dr. Badmaev has dedicated his career to the research and development of nutraceuticals and natural pharmaceutical products. He conceptualized the Interactive Nutrients Process (INP), a method that integrates the knowledge of botanicals with pharmacological science to develop “smart drugs” using artificial intelligence. His work has been instrumental in the advancement of various nutraceutical formulations, including C3Complex® (Sabinsa), Gugulipid® (Sabinsa), SeleniumSelect® (Sabinsa), Lactospore® (Sabinsa), Xanthigen® (PLThomas), RhodioLife® (PLThomas/Polyphenoles Naturales), Zembrin® (PLThomas/HGH), 5-Loxin®/Apres-Flex® (PLThomas), and MenaQ7® (NattoPharma). Furthermore, he has been actively involved in developing natural therapeutics such as Adaptrin®, GreenSelenium®, TurmericImmune®, SlimTrym®, and FB3® under American Medical Holdings Inc. His recent work focuses on the natural ginger phenolic derivative, 6-Shogaol, for managing iron overload and early-stage myelodysplastic syndromes (MDS). This breakthrough has resulted in a US patent, No.: US 10,864,174 B2 (2017), along with 11 related patents worldwide (2017-2024).

🏆Accolades and Recognition 

Between 1999 and 2009, Dr. Badmaev was the runner-up or recipient of four New Jersey R&D Council Thomas Alva Edison Awards. These accolades were awarded in recognition of his contributions to scientific research and patent innovations, including US patents #5,536,506, #5,804,596, #6,849,645, and #7,063,861. His extensive work in the field of nutraceutical research has earned him international recognition, leading to collaborations and multiple patent approvals in various countries, including Australia, Canada, New Zealand, Mexico, Brazil, South Africa, the European Community, Japan, Korea, India, and China.

🌍 Impact and Influence 

Community Impact

Dr. Badmaev’s influence extends beyond research and development. His contributions to literature have enriched the understanding of traditional medicine’s integration with modern healthcare. In 1999, he authored a chapter on Tibetan medicine in a medical textbook for students and healthcare professionals, edited by Wayne Jonas and Jeffrey Levine. A decade later, in 2009, he contributed to a chapter on curcuminoids in a book on alternative treatments in medicine by Raymond Cooper and Fredi Kronenberg. His scholarly work has provided valuable insights into the therapeutic applications of botanical medicine.

🔮Legacy and Future Contributions 

Dr. Badmaev’s contributions have left a lasting impact on the field of integrative medicine. His membership in esteemed medical and scientific societies, including the International Society of Immunopharmacology (1982), the American Association of Clinical Pathologists (1983), the American Medical Association (1984), and the Research and Development Council of New Jersey (1996), underscores his commitment to advancing medical science. His ongoing research into the development of AI-driven “smart drugs” signifies his vision for the future of medicine.

 

Conclusion

Vladimir Badmaev, MD, PhD, has dedicated his career to harmonizing traditional botanical medicine with scientific innovation. His pioneering research, extensive patent portfolio, and contributions to the nutraceutical industry exemplify his lifelong mission to develop safe and effective medical solutions. As he continues his work on AI-integrated nutraceuticals, his legacy serves as an inspiration for future generations in the field of integrative medicine.

📚Publications

Interactive Nutrient Process (INP) in a Generative AI of a New Drug—6-Shogaol as a Potential Case

Authors: Vladimir Badmaev

Journals: Drug Design, Development and Therapy

Vitamin K Insufficiency in the Indian Population: Pilot Observational Epidemiology Study

Authors: Rama Vaidya; Ashok D B Vaidya; Jayesh Sheth; Shashank Jadhav; Umakant Mahale; Dilip Mehta; Janusz Popko; Vladimir Badmaev; Sidney J Stohs

Journals: JMIR Public Health and Surveillance

Is 6-Shogaol an Effective Phytochemical for Patients With Lower-risk Myelodysplastic Syndrome? A Narrative Review

Authors: Soo Liang Ooi; Ron Campbell; Sok Cheon Pak; Terry Golombick; Arumugam Manoharan; Raj Ramakrishna; Vladimir Badmaev; Janet Schloss

Journals: Integrative Cancer Therapies

Proof‐of‐Concept Randomized Controlled Study of Cognition Effects of the Proprietary Extract Sceletium tortuosum (Zembrin) Targeting Phosphodiesterase‐4 in Cognitively Healthy Subjects: Implications for Alzheimer’s Dementia

Authors: Simon Chiu; Nigel Gericke; Michel Farina-Woodbury; Vladimir Badmaev; Hana Raheb; Kristen Terpstra; Joalex Antongiorgi; Yves Bureau; Zack Cernovsky; Jirui Hou et al.

Journals: Evidence-Based Complementary and Alternative Medicine

Veit Phillip | Medicine | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Veit Phillip – Medicine – Best Researcher Award

Leadership and Professional Roles:

Dr. Phillip holds a senior position as a physician at the Klinikum rechts der Isar, Technical University of Munich, where he leads the interdisciplinary pancreas conference, showcasing his leadership and expertise in clinical settings. His membership in several professional societies and editorial boards, such as the German Society for Internal Medicine and the Editorial Board of “Gastroenterology Review,” highlights his influence and standing in the medical community.

TUM School of Medicine and Health, Technical University of Munich | Germany

Profiles 

Scopus

📍Current Position

Dr. med. Veit Thomas Phillip currently holds the position of Senior Physician at the Clinic and Polyclinic for Internal Medicine II at Klinikum rechts der Isar, Technical University of Munich. He has been serving in this role since October 2019, where he oversees patient care, contributes to medical research, and leads the interdisciplinary pancreas conference (“Pancreas Board”) initiated in October 2018. His responsibilities also include mentoring junior doctors, collaborating with other specialists, and managing complex cases in internal medicine and gastroenterology.

📝Publication Achievements 

Journals Published

“I am losing weight unintentionally.” (2024) – A paper exploring unintentional weight loss in gastroenterology patients, published in MMW Fortschr Med. “Gut microbiota predicts severity and reveals novel metabolic signatures in acute pancreatitis.” (2023) – A significant study in Gut that examines the relationship between gut microbiota and the severity of acute pancreatitis. “Comparison of endoscopic ultrasound-guided fine-needle aspiration and fine-needle biopsy to generate pancreatic cancer organoids: Randomized trial.” (2024) – Published in Endosc Int Open, this research compares biopsy methods in pancreatic cancer diagnosis.

 🔍Ongoing Research 

Dr. Phillip is deeply involved in ongoing research projects focusing on the epidemiology and treatment of acute pancreatitis, pancreatic cancer, and the role of microbiota in gastrointestinal diseases. His research aims to improve diagnostic accuracy, patient outcomes, and the understanding of disease mechanisms. One of his notable projects is a randomized trial comparing endoscopic ultrasound-guided biopsy techniques for pancreatic cancer, which has the potential to revolutionize diagnostic procedures in oncology.

 🔬Research Interests 

Gastroenterology: Specializing in pancreatitis, pancreatic cancer, and gastrointestinal disorders. Microbiota: Exploring the gut microbiota’s role in gastrointestinal diseases and its potential as a therapeutic target. Medical Imaging: Advancing imaging techniques in gastroenterology, particularly in the early detection of pancreatic lesions. Machine Learning: Integrating AI and machine learning into clinical practice to enhance diagnostic accuracy and treatment planning.

🎓Academic Background 

Dr. Phillip’s academic journey began at Camerloher-Gymnasium Freising, where he completed his general higher education entrance qualification in 1998. He pursued human medicine at the Justus-Liebig University of Giessen (2000-2002) and continued his studies at the University of Regensburg, where he completed his state examination in 2006. His academic achievements include a doctoral degree (Dr. med.) in 2007, with a dissertation on interferon-α’s role in experimental colitis, earning the distinction magna cum laude. He further specialized in internal medicine and gastroenterology, achieving multiple certifications, including a postdoctoral lecture qualification in 2017.

 🏆Scholarships and Awards 

Research Funding (2010): Awarded by the Kuratorium für Klinische Forschung, Technical University of Munich, for his project on liver disease and transplantation, with a grant of €60,000. Abraham Vater Prize for Clinical Pancreas Research: Received twice (2012, 2014) for his groundbreaking work in pancreatology. Colorectal Cancer Prevention Prize 2024: Awarded by the LebensBlicke Foundation, recognizing his contributions to cancer prevention research.

 🌐Professional Associations 

German Society for Internal Medicine: Member since 2010, contributing to the field of internal medicine through research and clinical practice. Society for Gastroenterology in Bavaria: Member since 2008, where he collaborates with other specialists to advance gastroenterology in the region. German Pancreas Club: A member since 2013, actively participating in research and discussions related to pancreatic diseases.

 📚Training & Workshops 

Dr. Phillip regularly participates in training sessions and workshops to stay updated with the latest medical advancements. His certifications in genetic counseling, radiation protection, and nutrition reflect his dedication to continuous professional development.

 🎤Oral Presentations 

Dr. Phillip has delivered numerous oral presentations at national and international conferences, sharing his research findings on gastroenterology, pancreatology, and internal medicine. His ability to communicate complex medical concepts effectively has earned him recognition as a leading expert in his field.

 🧑‍🔬Tasks Completed as a Researcher 

As a researcher, Dr. Phillip has completed various tasks, including conducting clinical trials, publishing scientific papers, mentoring junior researchers, and leading interdisciplinary research teams. His work has significantly contributed to the understanding of gastrointestinal diseases and the development of new diagnostic and therapeutic approaches.

 🚀Success Factors 

Dr. Phillip attributes his success to a combination of rigorous academic training, continuous learning, collaboration with experts across disciplines, and a passion for improving patient care. His ability to integrate research into clinical practice has been a key factor in his professional achievements.

 🧪Publications & Laboratory Experience

Dr. Phillip’s laboratory experience includes working on cutting-edge research in gastroenterology, particularly in the study of pancreatitis and pancreatic cancer. His publications in prestigious journals are a testament to his expertise and contributions to medical science.

📚Publications: